Bml Capital Management, LLC Kinnate Biopharma Inc. Transaction History
Bml Capital Management, LLC
- $149 Billion
- Q1 2024
A detailed history of Bml Capital Management, LLC transactions in Kinnate Biopharma Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 498,851 shares of KNTE stock, worth $0. This represents 0.89% of its overall portfolio holdings.
Number of Shares
498,851
Previous 468,210
6.54%
Holding current value
$0
Previous $1.11 Billion
19.58%
% of portfolio
0.89%
Previous 0.84%
Shares
3 transactions
Others Institutions Holding KNTE
# of Institutions
63Shares Held
34.9MCall Options Held
94.7KPut Options Held
802K-
Foresite Capital Management Iv, LLC Larkspur, CA9.67MShares$013.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.01MShares$00.48% of portfolio
-
Foresite Capital Management V, LLC Larkspur, CA3.53MShares$015.38% of portfolio
-
Lynx1 Capital Management LP San Juan, PR1.98MShares$01.37% of portfolio
-
Viking Global Investors LP1.82MShares$00.02% of portfolio
About Kinnate Biopharma Inc.
- Ticker KNTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,145,600
- Description
- Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...